HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Predictive, protective, orphan autoantibodies: the example of anti-phospholipid antibodies.

Abstract
Anti-phospholipid antibodies (aPL) are one of the most recent examples of autoantibodies that can appear even long time before any clinical manifestation can be associated with them. There is a general agreement that they may represent a strong risk factor for recurrent thrombosis and/or fetal losses. Anti-phospholipid antibodies represent a necessary but not sufficient factor (first hit) for thrombosis, and require additional triggering factors (second hit) to disclose the thrombogenic activity. Several factors may affect the predictive value of aPL, including titre, immunoglobulin isotype, fine antigenic specificity and affinity binding activity. Their careful evaluation is suggested in order to characterize the true predictive value of aPL.
AuthorsPier Luigi Meroni, Yehuda Shoenfeld
JournalAutoimmunity reviews (Autoimmun Rev) Vol. 7 Issue 8 Pg. 585-7 (Sep 2008) ISSN: 1568-9972 [Print] Netherlands
PMID18706525 (Publication Type: Editorial, Review)
Chemical References
  • Antibodies, Antiphospholipid
  • Phospholipids
Topics
  • Animals
  • Antibodies, Antiphospholipid (biosynthesis, blood, physiology)
  • Antiphospholipid Syndrome (diagnosis, immunology, prevention & control)
  • Humans
  • Phospholipids (immunology)
  • Predictive Value of Tests
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: